Literature DB >> 12855694

PEA3 transactivates the Muc4/sialomucin complex promoter in mammary epithelial and tumor cells.

Aymee Perez1, Roy Barco, Isabel Fernandez, Shari A Price-Schiavi, Kermit L Carraway.   

Abstract

Sialomucin complex (SMC, rat Muc4) is a heterodimeric glycoprotein composed of two subunits, the mucin component ascites sialoglycoprotein ASGP-1 and the transmembrane subunit ASGP-2, which is aberrantly expressed on the surfaces of a variety of tumor cells. Up-regulation of the Muc4/SMC gene in the 13762 sublines of the rat mammary adenocarcinoma correlates with the overexpression of transcription factor PEA3 and the receptor tyrosine kinase ErbB2. Here we report that PEA3 is capable of transactivating the Muc4/SMC promoter in a dose-dependent manner via direct attachment to a PEA3 binding site. ERM and ER81, the other two members of the PEA3 subfamily of transcription factors, could not transactivate the Muc4/SMC promoter. Transcriptional activation of Muc4/SMC by PEA3 is potentiated by Ras and MEKK1 kinases. These data suggest that expression of PEA3 in mammary tumors leads to up-regulation of Muc4/SMC transcription, the gene product of which may contribute to the metastatic potential of mammary tumors.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12855694     DOI: 10.1074/jbc.M300264200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  8 in total

1.  Upregulation of mucin4 in ER-positive/HER2-overexpressing breast cancer xenografts with acquired resistance to endocrine and HER2-targeted therapies.

Authors:  Albert C Chen; Ilenia Migliaccio; Mothaffar Rimawi; Sara Lopez-Tarruella; Chad J Creighton; Suleiman Massarweh; Catherine Huang; Yen-Chao Wang; Surinder K Batra; M Carolina Gutierrez; C Kent Osborne; Rachel Schiff
Journal:  Breast Cancer Res Treat       Date:  2012-05-29       Impact factor: 4.872

2.  MKP1 regulates the induction of MUC5AC mucin by Streptococcus pneumoniae pneumolysin by inhibiting the PAK4-JNK signaling pathway.

Authors:  Un-Hwan Ha; Jae Hyang Lim; Hyun-Joong Kim; Weihui Wu; Shouguang Jin; Haidong Xu; Jian-Dong Li
Journal:  J Biol Chem       Date:  2008-09-09       Impact factor: 5.157

Review 3.  Muc4/MUC4 functions and regulation in cancer.

Authors:  Kermit L Carraway; George Theodoropoulos; Goldi A Kozloski; Coralie A Carothers Carraway
Journal:  Future Oncol       Date:  2009-12       Impact factor: 3.404

4.  The antagonistic regulation of human MUC4 and ErbB-2 genes by the Ets protein PEA3 in pancreatic cancer cells: implications for the proliferation/differentiation balance in the cells.

Authors:  Valérie Fauquette; Michael Perrais; Sylvain Cerulis; Nicolas Jonckheere; Marie-Paule Ducourouble; Jean-Pierre Aubert; Pascal Pigny; Isabelle Van Seuningen
Journal:  Biochem J       Date:  2005-02-15       Impact factor: 3.857

Review 5.  The role of membrane mucin MUC4 in breast cancer metastasis.

Authors:  Courtney A Dreyer; Kacey VanderVorst; Savannah Free; Ashley Rowson-Hodel; Kermit L Carraway
Journal:  Endocr Relat Cancer       Date:  2021-11-24       Impact factor: 5.678

6.  Transcript profiling of Elf5+/- mammary glands during pregnancy identifies novel targets of Elf5.

Authors:  Renee L Rogers; Isabelle Van Seuningen; Jodee Gould; Paul J Hertzog; Matthew J Naylor; Melanie A Pritchard
Journal:  PLoS One       Date:  2010-10-07       Impact factor: 3.240

7.  Pea3 transcription factors and wnt1-induced mouse mammary neoplasia.

Authors:  Rebecca Baker; Claire V Kent; Rachel A Silbermann; John A Hassell; Lawrence J T Young; Louise R Howe
Journal:  PLoS One       Date:  2010-01-22       Impact factor: 3.240

Review 8.  Mucins in the mucosal barrier to infection.

Authors:  S K Linden; P Sutton; N G Karlsson; V Korolik; M A McGuckin
Journal:  Mucosal Immunol       Date:  2008-03-05       Impact factor: 7.313

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.